Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hyperandrogenism × Acupuncture Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 51 Neoplasms 19 Pain 17 Fatigue 10 Prostatic Neoplasms 9 Multiple Myeloma 9 Hot Flashes 9 Lung Neoplasms 8 Polycystic Ovary Syndrome 7 Peripheral Nervous System Diseases 7 Anxiety Disorders 6 Stomach Neoplasms 5 Sleep Initiation and Maintenance Disorders 5 Depression 5 Colorectal Neoplasms 5 Agnosia 5 Pancreatic Neoplasms 4 Lymphoma 4 Lymphedema 4 Insulin Resistance 4 Head and Neck Neoplasms 4 Xerostomia 3 Squamous Cell Carcinoma of Head and Neck 3 Nasopharyngeal Neoplasms 3 Lymphoma, Non-Hodgkin 3 Gastrointestinal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Cancer Pain 3 Vomiting 2 Salivary Gland Neoplasms 2

Interventions

Metformin 7 Progesterone 5 Spironolactone 4 drospirenone and ethinyl estradiol combination 3 Inositol 3 Ethinyl Estradiol 3 salicylsalicylic acid 2 Folic Acid 2 Flutamide 2 Cyproterone Acetate 2 Clomiphene 2 maltodextrin 1 licogliflozin 1 bicalutamide 1 Yoga 1 Waist-Hip Ratio 1 Waist Circumference 1 Ultrasonography 1 Topiramate 1 Time 1 Thioctic Acid 1 Sugars 1 Sodium Salicylate 1 Physical Examination 1 Phlebotomy 1 Phenotype 1 Ovidrel 1 Magnesium 1 Lactalbumin 1 Inulin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02647827 2024-10-09

PIAII

Karolinska Institutet

Phase 2 Recruiting

Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡